Multiple Myeloma Clinical Trial
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Summary
A Randomized, Double-Blind, Placebo-Controlled, Parallel, Multi-Center Study to Assess the Efficacy of BRCX014 Combined with Standard-Of-Care Treatment in Subjects with Glioblastoma Multiforme, Multiple Myeloma, and GI Malignancies
Full Description
Several studies have shown a potential anti-tumor role for cannabinoids by modulating cell signaling pathways, inhibiting angiogenesis, inducing apoptosis, and overcoming chemotherapy resistance. In phase I trials, cannabinoids have been shown to enhance the uptake of chemotherapy into malignant cells without affecting normal cells. The investigators seeks to demonstrate that the combination of chemotherapy with BRCX014 will have a greater anti-tumor and anti-proliferative activity when compared to standard of care alone.
Eligibility Criteria
Inclusion Criteria:
Signed and dated informed consent
Male and Females age 18 to 80 years old at the time of screening
Confirmed tissue diagnosis of Multiple myeloma, GI malignancy by a licensed pathologist
A performance status 0-1 on the Eastern Cooperative Oncology Group (ECOG) scale.
Females of childbearing potential willing to utilize two approved forms of contraceptives (e.g., birth control, abstinence, spermicidal lube, intrauterine device [IUD])
Male study subjects must be willing to use two approved forms of contraceptives (e.g., physical barrier-condoms, abstinence, spermicidal lube)
Exclusion Criteria:
Subject is pregnant or plans to become pregnant or actively lactating/nursing
Hypersensitivity to any ingredient in the study product
Initial laboratory values as determined by the principal investigator to be clinically significant
A substance abuse history within the last five years
Any diseases or conditions that may interfere with the conduct of the study or interpretation of the study results
.Close affiliation with the investigational site (e.g., a close relative of the investigator), dependent person (employee or student of investigational site, or sponsor's staff)
Currently enrolled in another investigational clinical study
A known history of severe depression or psychiatric disorders or active suicidal ideation
Inability or unwillingness to cooperate with the study procedures for any reasons
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.